2025 third_quarter Filing

Pennsylvania is a global leader in researching and developing new therapies, cures, and devices that help patients live longer, healthier lives. This innovation is due in part to the policy and regulatory ecosystem we enjoy in the United States. Life Sciences PA works annually with its Federal Policy Committee and national partners to develop a set of policy issues and recommendations that will support and enhance the countrys life sciences ecosystem and maintains Pennsylvanias leadership in life sciences innovation. As the statewide Trade Association for the Life Sciences, our Public Policy advocacy work remains to engage and educate the Pennsylvania Congressional Delegation to incentivize innovation and protect patient access.

As the statewide Trade Association for the Life Sciences, our Public Policy advocacy work remains to engage and educate the Pennsylvania Congressional Delegation to incentivize innovation and protect patient access. Ensuring Patient Access to Critical Breakthrough Products Act (HR 5343/S1717). This legislation provides Medicare coverage for medical devices approved through the FDAs Breakthrough Devices Program. Without this legislation, devices receiving the Breakthrough Device designation and approval must often wait upwards of two to three years for payment codes from the Centers for Medicare and Medicaid Services. Without this legislation, patients in Medicare face coverage and reimbursement delays in access to life-changing innovations.